Nautilus Biotechnolgy, Inc. (NAUT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 246.2M |
| Enterprise Value | 263.83M |
| P/E Ratio | -4.36 |
| PEG Ratio | -0.29 |
| Price/Sales Ratio | 1,312.74 |
| Price/Book Ratio | 1.9 |
| Enterprise/Revenue | 1,389.84 |
| Enterprise/EBITDA | -4.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -297.48 |
| Operating Margin | -330.44 |
| Return On Assets | -0.35 |
| Return On Equity | -0.38 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -6.47M |
| EBITDA | -52.54M |
| Net Income | -59M |
| Diluted EPS | -0.47 |
| Total Cash | 84.03M |
| Total Cash/Share | 0.66 |
| Total Debt | 27.82M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 10.14 |
| Book Value Per Share | 1.03 |
| 52-Week Change | 126.56 |
| 52-Week High | 4.31 |
| 52-Week Low | 0.82 |
| Moving Average 50 Days | 1.03 |
| Moving Average 200 Days | 2.07 |
| Average Volume | 1.77M |
| Shares Outstanding | 127.26M |
| % Held by Institutions | 39.62 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |